Last reviewed · How we verify
NCT05760274
Esophageal pH-MII Duration: 12 or 24 Hours?
trial testing multichannel intraluminal impedance and pH monitoring (MII/pH) in Gastro Esophageal Reflux in 127 participants. Completed in 15 February 2025.
15 February 2025
Quick facts
| Lead sponsor | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 127 |
| Start date | 13 July 2022 |
| Primary completion | 15 February 2025 |
| Estimated completion | 15 February 2025 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- multichannel intraluminal impedance and pH monitoring (MII/pH)
Conditions studied
- Gastro Esophageal Reflux — all drugs for Gastro Esophageal Reflux →
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Who can join
Adults 1 Day to 12 Months, any sex, with Gastro Esophageal Reflux. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To check whether the first 12 hours of MII-pH recording are sufficient to diagnose gastroesophageal reflux disease (GERD) among newborns/infants, with a diagnostic accuracy similar to 24 hours of recording as currently advised.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05760274
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gastro Esophageal Reflux
Currently open trials in the same condition.
- NCT07482969 — Prevalence of Symptomatic Gastroesophageal Reflux Disease in Czech Children (Czech GERDKids) · recruiting
- NCT05455359 — Gastrointestinal Dysmotility on Aspiration Risk · Phase 4 · recruiting
- NCT07131397 — The Effect of Inspiratory Muscle Training in People With Gastroesophageal Reflux Disease · NA · recruiting
- NCT06564558 — The Effect of Postural Correction On Gastroesophageal Reflux Disease · NA · recruiting
- NCT05570448 — Anti-Reflux Endoscopic TX Using APC (AREA) in GERD Patients: (The AREA Study) · NA · recruiting
Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials
Trials by the same sponsor.
- NCT07514572 — Impact of Estimated Weight and Height on Nutritional Assessment in Elderly · NA · not yet recruiting
- NCT07504679 — Adipose Visceral and Epicardial Risk Evaluation · NA · not yet recruiting
- NCT07520643 — MISTIC Study: Atherosclerosis, Neurocognition & Cardiovascular Signaling · not yet recruiting
- NCT07479238 — Breath Test-Based Assessment of SIBO in Chronic Pancreatitis and Partial Pancreatectomy · not yet recruiting
- NCT07494227 — Development of the SC-IBD Self-Care Measurement Scale · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05760274 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Last refreshed: 11 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05760274.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing